Enhancing the eyes: Use of minimally invasive techniques for periorbital rejuvenation

Journal of Drugs in Dermatology

Volumn 9, Issue 8, 2010, Pages

  Glaser, Dee Anna ^a   Patel, Utpal ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYACID; AZELAIC ACID; BIMATOPROST; BLEACHING AGENT; BOTULINUM TOXIN; COSMETIC; FILLER; GLYCOLIC ACID; HYDROQUINONE; LACTIC ACID; MELANIN; NON PRESCRIPTION DRUG; PROSTAGLANDIN RECEPTOR; RETINOID; SUNSCREEN; TRICHLOROACETIC ACID;

ACNE; ACTINIC KERATOSIS; AGING; ANATOMY; ANGIOGENESIS; CARBON DIOXIDE LASER; CARCINOGENESIS; CHEMICAL PEEL; CONFERENCE PAPER; CONJUNCTIVAL HYPEREMIA; CONTACT DERMATITIS; COSMETIC INDUSTRY; CUTANEOUS PARAMETERS; DRUG APPROVAL; DRUG EFFICACY; ERBIUM YAG LASER; ERYTHEMA; ESTHETIC SURGERY; ESTHETICS; EYE; EYE DRYNESS; EYEBROW; FOREHEAD; GLABELLAR COMPLEX; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; HYPOTRICHOSIS; INFECTION; INTRAOCULAR HYPERTENSION; IRIS PIGMENTATION; LASER SURGERY; LOW LEVEL LASER THERAPY; LOWER EYELID; MINIMALLY INVASIVE PROCEDURE; MUSCLE WEAKNESS; NEUROMODULATION; OPEN ANGLE GLAUCOMA; PATIENT EDUCATION; PERIOCULAR HYPERPIGMENTATION; PERIORBITAL REJUVENATION; PHOTOAGING; PHOTODYNAMIC THERAPY; PIGMENTATION; PRURITUS; RADIOFREQUENCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REJUVENATION; RHYTIDOPLASTY; SCAR; SIDE EFFECT; SKIN ABRASION; SKIN DISCOLORATION; SKIN EXFOLIATION; SKIN IRRITATION; SUN EXPOSURE; TEAR TROUGH; TELANGIECTASIA; ULTRAVIOLET RADIATION; UPPER EYELID; WRINKLE; ORBIT; REVIEW;

COSMETIC TECHNIQUES; EYE; HUMANS; ORBIT; REJUVENATION; SKIN AGING;

EID: 77956215430     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (76)

1. Langlois JH, Kalakanis L, Rubenstein AJ, et al. Maxims or myths of beauty? A meta-analytic and theoretical review. Psychol Bull. 2000;126(3):390-423.
2. Eagly AH, Makhijani MG, Ashmore RD, Longo LC. What is beautiful is good, but...: A meta-analytic review of research on the physical attractiveness stereotype. Psychol Bull. 1991;110(1):109-128.
3. McCurdy JA, Jr. Beautiful eyes: Characteristics and application to aesthetic surgery. Facial Plast Surg. 2006;22(3):204-214.
4. Volpe CR, Ramirez OM. The beautiful eye. Facial Plast Surg Clin North Am. 2005;13(4):493-504. (Pubitemid 41631151)
5. Ross AT, Neal JG. Rejuvenation of the aging eyelid. Facial Plast Surg. 2006;22(2):97-104. (Pubitemid 44156404)
6. Rohrich RJ, Coberly DM, Fagien S, Stuzin JM. Current concepts in aesthetic upper blepharoplasty. Plast Reconstr Surg. 2004;113(3):32e-42e.
7. Friedman O. Changes associated with the aging face. Facial Plast Surg Clin North Am. 2005;13(3):371-380. (Pubitemid 41110310)
8. Randall VA. Hormonal regulation of hair follicles exhibits a biological paradox. Semin Cell Dev Biol. 2007;18(2):274-285. (Pubitemid 46756370)
9. Cohen JL. Enhancing the growth of natural eyelashes: The mechanism of bimatoprost-induced eyelash growth. Dermatol Surg. 1 Apr 2010. [Epud ahead of print]
10. Khong JJ, Casson RJ, Huilgol SC, Selva D. Madarosis. Surv Ophthalmol. 2006;51(6):550-560. (Pubitemid 44667704)
11. Na JI, Kwon OS, Kim BJ, et al. Ethnic characteristics of eyelashes: A comparative analysis in Asian and Caucasian females. Br J Dermatol. 2006;155(6):1170-1176. (Pubitemid 44729991)
12. Randall VA. Androgens and hair growth. Dermatol Ther. 2008;21(5):314-328.
13. DeMello M. Encyclopedia of Body Adornment. Westport, CN: Greenwood Press; 2007.
14. Hunt N, McHale S. The psychological impact of alopecia. BMJ. 2005;331(7522):951-953. (Pubitemid 41510855)
15. Hirmand H. Anatomy and nonsurgical correction of the tear trough deformity. Plast Reconstr Surg. 2010;125(2):699-708.
16. Kranendonk S, Obagi S. Autologous fat transfer for periorbital rejuvenation: Indications, technique, and complications. Dermatol Surg. 2007;33(5):572-578. (Pubitemid 46650367)
17. Alex JC. Aesthetic considerations in the elevation of the eyebrow. Facial Plast Surg. 2004;20(3):193-198. (Pubitemid 40082872)
18. Gunter JP, Antrobus SD. Aesthetic analysis of the eyebrows. Plast Reconstr Surg. 1997;99(7):1808-1816. (Pubitemid 27255118)
19. Farkas LG. Anthropometry of the Head and Face. 2nd ed. New York: Raven Press; 1994.
20. Woodward DF, Liang Y, Krauss AH. Prostamides (prostaglandin- ethanolamides) and their pharmacology. Br J Pharmacol. 2008;153(3):410-419. (Pubitemid 351199006)
21. Patil AJ, Vajaranant TS, Edward DP. Bimatoprost-A review. Expert Opin Pharmacother. 2009;10(16):2759-2768.
22. Cohen JL. From serendipity to pilot study and then pivotal trial: Bimatoprost topical for eyelash growth. Dermatol Surg. 2010;36(5):650-651
23. Yoelin S, Walt JG, Earl M. Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth. Dermatol Surg. 2010;36(5):638-649.
24. Latisse [package insert]. Irvine CA, Inc.; 2008.
25. Galloway GD, Eke T, Broadway DC. Periocular cutaneous pigmentary changes associated with bimatoprost use. Arch Ophthalmol. 2005;123(11):1609-1610. (Pubitemid 41626702)
26. Stjernschantz JW, Albert DM, Hu DN, et al. Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol. 2002;47 Suppl 1:S162-S175. (Pubitemid 35232231)
27. Rendon-Pellerano M.I. BEF. The use of glycolic acids in the management of xerosis and photoaging. J Geriatr Dermatol. 1996;4 Suppl B:12B-16B.
28. Ditre CM, Griffin TD, Murphy GF, et al. Effects of alpha-hydroxy acids on photoaged skin: A pilot clinical, histologic, and ultrastructural study. J Am Acad Dermatol. 1996;34(2 Pt 1):187-195. (Pubitemid 26064761)
29. Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986;15(4 Pt 2):836-859. (Pubitemid 17170790)
30. Kang S, Fisher GJ, Voorhees JJ. Photoaging and topical tretinoin: Therapy, pathogenesis, and prevention. Arch Dermatol. 1997;133(10):1280-1284. (Pubitemid 27443821)
31. Weinstein GD, Nigra TP, Pochi PE, et al. Topical tretinoin for treatment of photodamaged skin. A multicenter study. Arch Dermatol. 1991;127(5):659-665.
32. Bhawan J, Gonzalez-Serva A, Nehal K, et al. Effects of tretinoin on photodamaged skin. A histologic study. Arch Dermatol. 1991;127(5):666-672.
33. Olsen EA, Katz HI, Levine N, et al. Tretinoin emollient cream for photodamaged skin: Results of 48-week, multicenter, double-blind studies. J Am Acad Dermatol. 1997;37(2 Pt 1):217-226. (Pubitemid 27355707)
34. Nelson BR, Majmudar G, Griffiths CE, et al. Clinical improvement following dermabrasion of photoaged skin correlates with synthesis of collagen I. Arch Dermatol. 1994;130(9):1136-1142. (Pubitemid 24288472)
35. Fulton JE, Jr. Dermabrasion, chemabrasion, and laserabrasion. Historical perspectives, modern dermabrasion techniques, and future trends. Dermatol Surg. 1996;22(7):619-628.
36. Orentreich N, Orentreich DS. Dermabrasion. Dermatol Clin. 1995;13(2):313-327.
37. Bolognia J, Jorizzo JL, Rapini RP. Dermatology. 2nd ed. St. Louis, Mo.; London: Mosby Elsevier; 2008.
38. Benedetto AV, Griffin TD, Benedetto EA, Humeniuk HM. Dermabrasion: Therapy and prophylaxis of the photoaged face. J Am Acad Dermatol. 1992;27(3):439-447.
39. Rubin MG. Chemical peels. Philadelphia: Elsevier Saunders; 2006.
40. Bosniak S, Cantisano-Zilkha M, Purewal BK, Zdinak LA. Combination therapies in oculofacial rejuvenation. Orbit. 2006;25(4):319-326. (Pubitemid 46012402)
41. Brody HJ. Chemical Peeling and Resurfacing. 2nd ed. ed. St. Louis; London: Mosby; 1997.
42. Brodland DG, Cullimore KC, Roenigk RK, Gibson LE. Depths of chemexfoliation induced by various concentrations and application techniques of trichloroacetic acid in a porcine model. J Dermatol Surg Oncol. 1989;15(9):967-971. (Pubitemid 19256575)
43. Manaloto RM, Alster TS. Periorbital rejuvenation: A review of dermatologic treatments. Dermatol Surg. 1999;25(1):1-9. (Pubitemid 29242724)
44. Resnik SS, Resnik BI. Complications of chemical peeling. Dermatol Clin. 1995;13(2):309-312.
45. Shook BA, Hruza GJ. Periorbital ablative and nonablative resurfacing. Facial Plast Surg Clin North Am. 2005;13(4):571-582 (Pubitemid 41631159)
46. Nanni CA, Alster TS. Complications of cutaneous laser surgery. A review. Dermatol Surg. 1998;24(2):209-219. (Pubitemid 28096114)
47. Bernstein LJ, Kauvar AN, Grossman MC, Geronemus RG. The short- and long-term side effects of carbon dioxide laser resurfacing. Dermatol Surg. 1997;23(7):519-525. (Pubitemid 27305248)
48. Sriprachya-Anunt S, Fitzpatrick RE, Goldman MP, Smith SR. Infections complicating pulsed carbon dioxide laser resurfacing for photoaged facial skin. Dermatol Surg. 1997;23(7):527-535.
49. Rubenstein R, Roenigk HH, Jr., Stegman SJ, Hanke CW. Atypical keloids after dermabrasion of patients taking isotretinoin. J Am Acad Dermatol. 1986;15(2 Pt 1):280-285. (Pubitemid 16070357)
50. Alster TS, Nanni CA, Williams CM. Comparison of four carbon dioxide resurfacing lasers. A clinical and histopathologic evaluation. Dermatol Surg. 1999;25(3):153-158.
51. Ross EV, Grossman MC, Duke D, Grevelink JM. Long-term results after CO2 laser skin resurfacing: A comparison of scanned and pulsed systems. J Am Acad Dermatol. 1997;37(5 Pt 1):709-718. (Pubitemid 27500313)
52. Kauvar AN, Waldorf HA, Geronemus RG. A histopathological comparison of "char-free" carbon dioxide lasers. Dermatol Surg.1996;22(4):343-348.
53. Alster TS, Garg S. Treatment of facial rhytides with a high-energy pulsed carbon dioxide laser. Plast Reconstr Surg. 1996;98(5):791-794. (Pubitemid 26322157)
54. Caniglia RJ. Erbium:YAG laser skin resurfacing. Facial Plast Surg Clin North Am. 2004;12(3):373-377. (Pubitemid 38992370)
55. Zelickson BD, Kilmer SL, Bernstein E, et al. Pulsed dye laser therapy for sun damaged skin. Lasers Surg Med. 1999;25(3):229-236. (Pubitemid 29466564)
56. Hohenleutner S, Hohenleutner U, Landthaler M. Nonablative wrinkle reduction: Treatment results with a 585-nm laser. Arch Dermatol. 2002;138(10):1380-1381.
57. Goldberg DJ, Whitworth J. Laser skin resurfacing with the Qswitched Nd:YAG laser. Dermatol Surg. 1997;23(10):903-906.
58. Dayan SH, Vartanian AJ, Menaker G, et al. Nonablative laser resurfacing using the long-pulse (1064-nm) Nd:YAG laser. Arch Facial Plast Surg. 2003;5(4):310-315.
59. Kopera D, Smolle J, Kaddu S, Kerl H. Nonablative laser treatment of wrinkles: Meeting the objective? Assessment by 25 dermatologists. Br J Dermatol. 2004;150(5):936-939. (Pubitemid 38903526)
60. Abraham MT, Chiang SK, Keller GS, et al. Clinical evaluation of nonablative radiofrequency facial rejuvenation. J Cosmet Laser Ther. 2004;6(3):136-144. (Pubitemid 39647387)
61. Alster TS, Tanzi E. Improvement of neck and cheek laxity with a nonablative radiofrequency device: A lifting experience. Dermatol Surg. 2004;30(4 Pt 1):503-507. (Pubitemid 38529588)
62. Glavas IP, Purewal BK. Noninvasive techniques in periorbital rejuvenation. Facial Plast Surg. 2007;23(3):162-167. (Pubitemid 351325908)
63. Bitter PH. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg. 2000;26(9):835-842.
64. Goldberg DJ. Photodynamic therapy in skin rejuvenation. Clin Dermatol. 2008;26(6):608-613.
65. Carruthers J, Fagien S, Matarasso SL. Consensus recommendations on the use of botulinum toxin type a in facial aesthetics. Plast Reconstr Surg. 2004;114(6 Suppl):1S-22S. (Pubitemid 40354480)
66. Salti G, Ghersetich I. Advanced botulinum toxin techniques against wrinkles in the upper face. Clin Dermatol. 2008;26(2):182-191. (Pubitemid 351620986)
67. Maas CS. Botulinum neurotoxins and injectable fillers: Minimally invasive management of the aging upper face. Otolaryngol Clin North Am. 2007;40(2):283-290. (Pubitemid 46441285)
68. Frankel AS, Markarian A. Cosmetic treatments and strategies for the upper face. Facial Plast Surg Clin North Am. 2007;15(1):31-39.
69. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18(1):17-21.
70. Carruthers J, Carruthers A. Botulinum toxin in facial rejuvenation: An update. Dermatol Clin. 2009;27(4):417-425.
71. Brin MF. Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl. 1997;6:S146-168.
72. Spencer JM. Botulinum toxin B: The new option in cosmetic injection. J Drugs Dermatol. 2002;1(1):17-22.
73. Flynn TC, Clark RE II. Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: Rate of onset and radius of diffusion. Dermatol Surg. 2003;29(5):519-522. (Pubitemid 36583151)
74. De Paiva A, Meunier FA, Molgo J, et al. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A. 1999;96(6):3200-3205. (Pubitemid 29148868)
75. Hexsel DM, De Almeida AT, Rutowitsch M, et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Dermatol Surg. 2003;29(5):523-529. (Pubitemid 36583152)
76. Finn JC, Cox S. Fillers in the periorbital complex. Facial Plast Surg Clin North Am. 2007;15(1):123-132.